CryoTherapeutics Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 9
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $3.02M
Latest Deal Amount
  • Investors
  • 10

CryoTherapeutics General Information

Description

Developer of a cryotherapy system designed to offer treatment for coronary artery diseases. The company's system offers a novel catheter system, which utilizes cryo energy to treat and prevent heart attacks and focuses on the development, demonstration of clinical benefit and early-stage commercialization of a proprietary cryotherapy system in order to prevent heart attacks, enabling heart surgeons to ensure safety and efficacy of cryo energy in the cardiovascular system and extend the benefits of cryo energy to the problem of diseased coronary arteries.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Primary Office
  • Rue de Bruxelles 174
  • E40 Business Park
  • 4340 Awans
  • Belgium
+32 04 000 00 00

CryoTherapeutics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CryoTherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B) 19-Feb-2021 $3.02M 000.00 Completed Clinical Trials - Phase 1
5. Later Stage VC (Series B) 27-Jun-2019 00.000 000.00 Completed Clinical Trials - Phase 1
4. Grant 12-Apr-2019 00.000 000.00 Completed Pre-Clinical Trials
3. Later Stage VC (Series B) 22-Jun-2016 00.000 000.00 0000 Completed Startup
2. Early Stage VC (Series A) 06-May-2014 $8.99M $8.99M 000.00 Completed Startup
1. Seed Round 01-Dec-2009 Completed Startup
To view CryoTherapeutics’s complete valuation and funding history, request access »

CryoTherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a cryotherapy system designed to offer treatment for coronary artery diseases. The company's system offers
Therapeutic Devices
Awans, Belgium
9 As of 2021
000.00
00000000000 000.00

00000000

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliq
00000000000 0000000
Lexington, MA
00 As of 0000
00000
000000 - 000 00000

00000000

eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia
00000000 0000000
New York, NY
000 As of 0000
000000 - 000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CryoTherapeutics Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
RejuvenAir Venture Capital-Backed Lexington, MA 00 00000 000000 - 000 00000
0000000000000 Corporation New York, NY 000 000000 - 000
00000 0000000 Formerly VC-backed Saint Paul, MN 000 000.00 000000&0 000.00
You’re viewing 3 of 3 competitors. Get the full list »

CryoTherapeutics Executive Team (7)

Name Title Board Seat Contact Info
John Yianni Ph.D Co-Founder & Chief Executive Officer
Bertrand Grimmonpré Chief Financial Officer
Hikmat Hojeibane Chief Technology Officer
Maurice Buchbinder MD Co-Founder & Chief Medical Officer
You’re viewing 4 of 7 executive team members. Get the full list »

CryoTherapeutics Board Members (7)

Name Representing Role Since
Aristotelis Nastos Ph.D NRW.Bank Board Member 000 0000
Eric Brandt Self Board Member 000 0000
Joachim Rautter Ph.D Peppermint Venture Partners Board Member 000 0000
Karlheinz Schmelig Self Board Member 000 0000
Rainer Christine Earlybird Venture Capital Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

CryoTherapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CryoTherapeutics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Earlybird Venture Capital Venture Capital Minority 000 0000 000000 0
Noshaq Venture Capital Minority 000 0000 000000 0
Walloon Region Lender/Debt Provider 000 0000 000000 0
Creathor Venture Venture Capital Minority 000 0000 000000 0
KfW IPEX-Bank Investment Bank Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »